Senior Discovery Scientist in chorioretinal degenerations_1 year temporary contract
Roche
About this role
Senior scientific role within Roche’s Pharmaceutical Research and Early Development (pRED) Ophthalmology team based in Basel, focused on research into age-related macular degeneration and other retinochoroidal disorders. The position seeks an experienced academic or industry scientist with deep expertise in choroid biology and vision research to support target discovery and translational retinal studies in a collaborative environment.
Skills
Qualifications
About Roche
roche.comAs a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Recent company news
Roche chairman still expects diagnostics hit from US tariffs
4 days ago
Roche flunks its first-line degrader test | ApexOnco - Clinical Trials news and analysis
3 days ago
Roche to invest ₩710B in South Korea over five years
1 day ago
Roche Breast-Cancer Drug Combination Misses Target in Study
3 days ago
Lilly pledges $500M to South Korea biopharma industry, following Roche’s lead
1 day ago
About Roche
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Roche.
Salary
$129k – $175k
per year
More jobs at Roche
Similar Jobs
Senior Associate Scientist, Retinal Degeneration
Sanofi
Scientist, Retinal Degeneration
Sanofi
Senior Scientist - Target Discovery and Biology
Amgen
Principal Scientist, Retinal Degeneration
Sanofi
Genomic Data Scientist
Character Biosciences
Scientist I/Associate Scientist II, Transcriptional Profiling
AbbVie